142 related articles for article (PubMed ID: 11744615)
21. In vivo toxicity and pharmacokinetic features of the janus kinase 3 inhibitor WHI-P131 [4-(4'hydroxyphenyl)-amino-6,7- dimethoxyquinazoline.
Uckun FM; Ek O; Liu XP; Chen CL
Clin Cancer Res; 1999 Oct; 5(10):2954-62. PubMed ID: 10537365
[TBL] [Abstract][Full Text] [Related]
22. In vitro metabolism of CP-122,721 ((2S,3S)-2-phenyl-3-[(5-trifluoromethoxy-2-methoxy)benzylamino]piperidine), a non-peptide antagonist of the substance P receptor.
Obach RS; Margolis JM; Logman MJ
Drug Metab Pharmacokinet; 2007 Oct; 22(5):336-49. PubMed ID: 17965517
[TBL] [Abstract][Full Text] [Related]
23. The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6.
Desta Z; Wu GM; Morocho AM; Flockhart DA
Drug Metab Dispos; 2002 Mar; 30(3):336-43. PubMed ID: 11854155
[TBL] [Abstract][Full Text] [Related]
24. The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell line.
Avery ML; Meek CE; Audus KL
Placenta; 2003 Jan; 24(1):45-52. PubMed ID: 12495659
[TBL] [Abstract][Full Text] [Related]
25. Cytochrome P450 1A1/2 mediated metabolism of trans-stilbene in rats and humans.
Sanoh S; Kitamura S; Sugihara K; Ohta S
Biol Pharm Bull; 2002 Mar; 25(3):397-400. PubMed ID: 11913543
[TBL] [Abstract][Full Text] [Related]
26. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.
Wang RW; Liu L; Cheng H
Drug Metab Dispos; 1996 Jul; 24(7):786-91. PubMed ID: 8818577
[TBL] [Abstract][Full Text] [Related]
27. Characterization of diuron N-demethylation by mammalian hepatic microsomes and cDNA-expressed human cytochrome P450 enzymes.
Abass K; Reponen P; Turpeinen M; Jalonen J; Pelkonen O
Drug Metab Dispos; 2007 Sep; 35(9):1634-41. PubMed ID: 17576805
[TBL] [Abstract][Full Text] [Related]
28. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
[TBL] [Abstract][Full Text] [Related]
29. Evidence supporting the interaction of CYP2B4 and CYP1A2 in microsomal preparations.
Cawley GF; Zhang S; Kelley RW; Backes WL
Drug Metab Dispos; 2001 Dec; 29(12):1529-34. PubMed ID: 11717170
[TBL] [Abstract][Full Text] [Related]
30. In vitro metabolism of zolmitriptan in rat cytochromes induced with beta-naphthoflavone and the interaction between six drugs and zolmitriptan.
Yu LS; Yao TW; Zeng S
Chem Biol Interact; 2003 Dec; 146(3):263-72. PubMed ID: 14642738
[TBL] [Abstract][Full Text] [Related]
31. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes.
Piver B; Fer M; Vitrac X; Merillon JM; Dreano Y; Berthou F; Lucas D
Biochem Pharmacol; 2004 Aug; 68(4):773-82. PubMed ID: 15276085
[TBL] [Abstract][Full Text] [Related]
32. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
33. Human cytochrome P450-catalyzed conversion of the proestrogenic pesticide methoxychlor into an estrogen. Role of CYP2C19 and CYP1A2 in O-demethylation.
Stresser DM; Kupfer D
Drug Metab Dispos; 1998 Sep; 26(9):868-74. PubMed ID: 9733665
[TBL] [Abstract][Full Text] [Related]
34. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
35. In vitro metabolism of the analgesic bicifadine in the mouse, rat, monkey, and human.
Erickson DA; Hollfelder S; Tenge J; Gohdes M; Burkhardt JJ; Krieter PA
Drug Metab Dispos; 2007 Dec; 35(12):2232-41. PubMed ID: 17881661
[TBL] [Abstract][Full Text] [Related]
36. Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis.
Uckun FM; Erbeck D; Qazi S; Venkatachalam T; Tibbles HE; Vassilev A
Arzneimittelforschung; 2007; 57(6):320-9. PubMed ID: 17688077
[TBL] [Abstract][Full Text] [Related]
37. High performance liquid chromatography determination of cytochrome P450 1A and 2C activities in bovine liver microsomes.
Pegolo S; Merlanti R; Giantin M; Dacasto M; Montesissa C; Capolongo F
Vet J; 2010 Jan; 183(1):81-88. PubMed ID: 18815059
[TBL] [Abstract][Full Text] [Related]
38. cDNA cloning and characterization of feline CYP1A1 and CYP1A2.
Tanaka N; Miyasho T; Shinkyo R; Sakaki T; Yokota H
Life Sci; 2006 Nov; 79(26):2463-73. PubMed ID: 17097115
[TBL] [Abstract][Full Text] [Related]
39. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.
Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T
Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583
[TBL] [Abstract][Full Text] [Related]
40. Cyp1a2 protects against reactive oxygen production in mouse liver microsomes.
Shertzer HG; Clay CD; Genter MB; Schneider SN; Nebert DW; Dalton TP
Free Radic Biol Med; 2004 Mar; 36(5):605-17. PubMed ID: 14980704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]